Summary
70 / 100 · Bulios Score
What speaks for it
- Revenue grew by 20% a year over the last 3 years.
What to watch
- The share price is above the Bulios Fair Price.
- Analysts expect revenue to fall by 61% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 23.4 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 25% a year over 5 years. Over the last 3 years it grew by 20% a year. For the next fiscal year analysts expect revenue to fall by 61%.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 67 USD
- Sales and administration 25 USD
- Taxes and other -2.0 USD
- Net profit 9.7 USD
Net profit, industry median (Financial - Capital Markets) 20 USD
Out of every 100 USD of revenue, 9.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 2
- Hold 3
- Sell 0
Today's price within the analysts' price targets
The average target of $53 is 52% above today's price. 40% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Transaction And Clearing Fees 87%
- Access Fees 7.8%
- Market Data Fees 3.0%
- Product and Service, Other 2.0%
By region
The company reports no revenue by region.
Transaction And Clearing Fees brings in 87% of revenue.
Segments in detail